Verition Fund Management’s Aldeyra Therapeutics ALDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37,505
Closed -$216K 2872
2025
Q1
$216K Buy
+37,505
New +$216K ﹤0.01% 2366
2024
Q4
Sell
-33,530
Closed -$181K 2551
2024
Q3
$181K Sell
33,530
-186,297
-85% -$1M ﹤0.01% 2215
2024
Q2
$728K Sell
219,827
-720,571
-77% -$2.39M ﹤0.01% 1288
2024
Q1
$3.08M Sell
940,398
-384,436
-29% -$1.26M 0.02% 700
2023
Q4
$4.65M Buy
1,324,834
+389,561
+42% +$1.37M 0.04% 427
2023
Q3
$6.25M Buy
935,273
+5,199
+0.6% +$34.7K 0.07% 315
2023
Q2
$7.8M Sell
930,074
-634,954
-41% -$5.33M 0.1% 235
2023
Q1
$15.5M Buy
1,565,028
+6,706
+0.4% +$66.6K 0.22% 96
2022
Q4
$10.8M Sell
1,558,322
-843,917
-35% -$5.87M 0.17% 116
2022
Q3
$12.8M Buy
2,402,239
+501,048
+26% +$2.68M 0.14% 128
2022
Q2
$7.59M Sell
1,901,191
-204,716
-10% -$817K 0.15% 152
2022
Q1
$9.36M Buy
2,105,907
+739,206
+54% +$3.29M 0.11% 124
2021
Q4
$5.47M Buy
1,366,701
+718,494
+111% +$2.87M 0.04% 233
2021
Q3
$5.69M Buy
648,207
+120,376
+23% +$1.06M 0.05% 172
2021
Q2
$5.98M Buy
527,831
+111,114
+27% +$1.26M 0.05% 149
2021
Q1
$4.95M Buy
416,717
+219,963
+112% +$2.61M 0.06% 151
2020
Q4
$1.35M Sell
196,754
-99,426
-34% -$682K 0.01% 362
2020
Q3
$2.2M Buy
296,180
+274,180
+1,246% +$2.03M 0.04% 182
2020
Q2
$92K Buy
+22,000
New +$92K ﹤0.01% 928
2019
Q2
Sell
-275,205
Closed -$2.49M 950
2019
Q1
$2.49M Buy
275,205
+124,400
+82% +$1.12M 0.1% 137
2018
Q4
$1.25M Buy
+150,805
New +$1.25M 0.09% 182